Logos Global Management as of June 30, 2023
Portfolio Holdings for Logos Global Management
Logos Global Management holds 50 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals (APLS) | 7.7 | $57M | 625k | 91.10 | |
| Cytokinetics Com New (CYTK) | 7.3 | $54M | 1.7M | 32.62 | |
| Immunovant (IMVT) | 5.8 | $43M | 2.3M | 18.97 | |
| Ideaya Biosciences (IDYA) | 5.6 | $41M | 1.8M | 23.50 | |
| Sarepta Therapeutics (SRPT) | 4.7 | $34M | 300k | 114.52 | |
| Olema Pharmaceuticals (OLMA) | 4.6 | $34M | 3.7M | 9.03 | |
| Immunocore Hldgs Ads (IMCR) | 4.1 | $30M | 500k | 59.96 | |
| Biogen Idec (BIIB) | 3.9 | $29M | 100k | 284.85 | |
| Neurocrine Biosciences (NBIX) | 3.8 | $28M | 300k | 94.30 | |
| Miragen Therapeutics (VRDN) | 3.6 | $27M | 1.1M | 23.79 | |
| Akero Therapeutics (AKRO) | 3.3 | $24M | 520k | 46.69 | |
| Allakos (ALLK) | 3.1 | $23M | 5.3M | 4.36 | |
| Icosavax | 2.9 | $22M | 2.2M | 9.93 | |
| Dyne Therapeutics (DYN) | 2.7 | $20M | 1.8M | 11.25 | |
| Design Therapeutics (DSGN) | 2.4 | $18M | 2.8M | 6.30 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 2.3 | $17M | 400k | 41.57 | |
| Bridgebio Pharma Call Option (BBIO) | 2.2 | $16M | 950k | 17.20 | |
| Arcellx Common Stock (ACLX) | 2.2 | $16M | 500k | 31.62 | |
| Arcus Biosciences Incorporated (RCUS) | 2.1 | $15M | 750k | 20.31 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 1.8 | $13M | 520k | 25.52 | |
| Annexon (ANNX) | 1.7 | $12M | 3.5M | 3.52 | |
| Xenon Pharmaceuticals (XENE) | 1.4 | $11M | 275k | 38.50 | |
| Galapagos Nv Spon Adr (GLPG) | 1.4 | $10M | 250k | 40.66 | |
| Cogent Biosciences (COGT) | 1.3 | $9.5M | 800k | 11.84 | |
| Mersana Therapeutics (MRSN) | 1.3 | $9.2M | 2.8M | 3.29 | |
| Morphosys Sponsored Ads (MOR) | 1.2 | $9.0M | 1.2M | 7.47 | |
| BioMarin Pharmaceutical (BMRN) | 1.2 | $8.7M | 100k | 86.68 | |
| Ventyx Biosciences (VTYX) | 1.1 | $8.2M | 250k | 32.80 | |
| Day One Biopharmaceuticals I (DAWN) | 1.1 | $7.8M | 650k | 11.94 | |
| Karuna Therapeutics Ord | 1.0 | $7.6M | 35k | 216.85 | |
| Alx Oncology Hldgs (ALXO) | 1.0 | $7.5M | 1.0M | 7.51 | |
| Geron Corporation (GERN) | 1.0 | $7.1M | 2.2M | 3.21 | |
| Delcath Sys Com New (DCTH) | 0.9 | $6.9M | 1.2M | 5.83 | |
| Gracell Biotechnologies Sponsored Ads | 0.9 | $6.9M | 1.8M | 3.81 | |
| Enliven Therapeutics (ELVN) | 0.9 | $6.3M | 307k | 20.41 | |
| Immatics SHS (IMTX) | 0.8 | $5.8M | 500k | 11.54 | |
| Marinus Pharmaceuticals Com New (MRNS) | 0.8 | $5.7M | 525k | 10.86 | |
| Aclaris Therapeutics (ACRS) | 0.7 | $5.4M | 525k | 10.37 | |
| Kura Oncology (KURA) | 0.7 | $5.3M | 500k | 10.58 | |
| Rocket Pharmaceuticals (RCKT) | 0.7 | $5.0M | 250k | 19.87 | |
| Vir Biotechnology (VIR) | 0.7 | $4.9M | 200k | 24.53 | |
| Astria Therapeutics (ATXS) | 0.6 | $4.5M | 545k | 8.33 | |
| Tenaya Therapeutics (TNYA) | 0.5 | $3.5M | 600k | 5.87 | |
| Dbv Technologies S A Sponsored Adr | 0.3 | $2.3M | 1.2M | 1.90 | |
| Vigil Neuroscience (VIGL) | 0.2 | $1.8M | 188k | 9.40 | |
| Aeglea Biotherapeutics | 0.2 | $1.4M | 3.1M | 0.45 | |
| Immunic (IMUX) | 0.1 | $1.1M | 421k | 2.51 | |
| Lianbio Sponsored Ads (LIANY) | 0.1 | $638k | 280k | 2.28 | |
| Tyra Biosciences (TYRA) | 0.1 | $543k | 32k | 17.03 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $11k | 67k | 0.17 |
